| | | | | | | |
 | JOHNSON & JOHNSON | -0.06% | 0.93% | 4.51% | 12.17% | 28.10% | 467 679 |
| ELI LILLY AND COMPANY | -1.46% | 2.60% | 33.69% | 50.37% | 208.33% | 356 089 |
| ABBVIE INC. | 0.17% | 3.48% | 21.08% | 37.94% | 89.05% | 289 331 |
 | NOVO NORDISK A/S | 0.40% | 4.92% | 22.53% | 27.87% | 133.62% | 287 688 |
| MERCK & CO., INC. | -0.03% | 1.44% | 43.54% | 50.00% | 23.95% | 278 995 |
 | ROCHE HOLDING AG | 0.42% | -0.91% | -18.35% | -14.55% | 1.66% | 271 496 |
 | ASTRAZENECA PLC | 0.73% | 1.90% | 29.75% | 37.47% | 55.76% | 212 748 |
| NOVARTIS AG | 1.97% | 3.03% | 6.88% | 16.62% | -5.13% | 196 173 |
| BRISTOL-MYERS SQUIBB COMPANY | -0.53% | 2.39% | 29.43% | 43.29% | 35.68% | 180 080 |
| AMGEN INC. | -0.21% | 0.62% | 26.64% | 40.74% | 22.06% | 152 342 |
 | SANOFI | 0.44% | -2.22% | -2.55% | 2.34% | 3.30% | 113 255 |
| GILEAD SCIENCES, INC. | -1.18% | 3.21% | 21.17% | 26.48% | 33.44% | 111 665 |
| GSK PLC | -0.13% | 1.96% | -29.18% | -25.86% | -33.34% | 69 959 |
 | DAIICHI SANKYO CO., LTD. | 0.49% | -5.33% | 48.38% | 62.49% | 83.92% | 60 689 |
 | BAYER AG | -3.19% | -4.77% | 12.96% | 19.96% | -23.04% | 54 810 |
| | | | | | | |
| | Durchschnitt | -0.14% | 0.88% | 16.70% | 25.82% | 43.83% | |
| | Gewichteter Durchschnitt nach Marktkapitalisierung | -0.03% | 1.65% | 17.59% | 27.12% | 59.59% | |
Google
Twitter
Facebook
Apple
English (USA)
English (UK)
English (Canada)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (Nederland)
Nederlands (België)
Bericht
